Geron (GERN) Change in Cash (2010 - 2026)
Geron (GERN) posted Change in Cash of -$8.7 million for Q1 2026, down 1466.18% sequentially from -$553000.0 in Q4 2025, and down 282.95% YoY from $4.7 million in Q1 2025.
Geron (GERN) Change in Cash (2010 - 2026) Analysis & Trends
Geron has reported Change in Cash for 17 years, with the latest figure at -$8.7 million in Q1 2026.
- Quarterly Change in Cash fell 282.95% year-over-year to -$8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.8 million (up 85.91% YoY) and the FY2025 annual result came in at -$1.4 million, down 114.75% from the prior year.
- Change in Cash declined to -$8.7 million in Q1 2026 per GERN's latest filing, from -$553000.0 in the prior quarter.
- Over five years, Change in Cash peaked at $119.7 million in Q1 2024 and troughed at -$72.8 million in Q2 2024.
- A 5-year average of $2.1 million and a median of -$3.5 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2026: Change in Cash jumped 1677.35% in 2023, then plunged 282.95% in 2026.
- Over 5 years, Change in Cash stood at -$4.3 million in 2022, then surged by 1036.9% to $39.9 million in 2023, then slumped by 53.18% to $18.7 million in 2024, then slumped by 102.96% to -$553000.0 in 2025, then plunged by 1466.18% to -$8.7 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$8.7 million, -$553000.0, and $389000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | -6.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.25 Mn |
| Mar 31, 2026 | -8.66 Mn |
| Dec 31, 2025 | -553,000.00 |
| Sep 30, 2025 | 389,000.00 |
| Jun 30, 2025 | -6.01 Mn |
| Mar 31, 2025 | 4.73 Mn |
| Dec 31, 2024 | 18.68 Mn |
| Sep 30, 2024 | -55.87 Mn |
| Jun 30, 2024 | -72.81 Mn |
| Mar 31, 2024 | 119.74 Mn |
| Dec 31, 2023 | 39.89 Mn |
| Sep 30, 2023 | -26.19 Mn |
| Jun 30, 2023 | -55.70 Mn |
| Mar 31, 2023 | 55.93 Mn |
| Dec 31, 2022 | -4.26 Mn |
| Sep 30, 2022 | -14.95 Mn |
| Jun 30, 2022 | 44.73 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Sep 30, 2021 | -28.25 Mn |